RNA-based Biopharmaceuticals
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Monoclonal Antibody Service Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Reagents
1.2.3 Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Service Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostic Laboratories
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Service Market Perspective (2017-2028)
2.2 Monoclonal Antibody Service Growth Trends by Region
2.2.1 Monoclonal Antibody Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Monoclonal Antibody Service Historic Market Size by Region (2017-2022)
2.2.3 Monoclonal Antibody Service Forecasted Market Size by Region (2023-2028)
2.3 Monoclonal Antibody Service Market Dynamics
2.3.1 Monoclonal Antibody Service Industry Trends
2.3.2 Monoclonal Antibody Service Market Drivers
2.3.3 Monoclonal Antibody Service Market Challenges
2.3.4 Monoclonal Antibody Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Service Players by Revenue
3.1.1 Global Top Monoclonal Antibody Service Players by Revenue (2017-2022)
3.1.2 Global Monoclonal Antibody Service Revenue Market Share by Players (2017-2022)
3.2 Global Monoclonal Antibody Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Service Revenue
3.4 Global Monoclonal Antibody Service Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Service Revenue in 2021
3.5 Monoclonal Antibody Service Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Service Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Service Breakdown Data by Type
4.1 Global Monoclonal Antibody Service Historic Market Size by Type (2017-2022)
4.2 Global Monoclonal Antibody Service Forecasted Market Size by Type (2023-2028)
5 Monoclonal Antibody Service Breakdown Data by Application
5.1 Global Monoclonal Antibody Service Historic Market Size by Application (2017-2022)
5.2 Global Monoclonal Antibody Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Monoclonal Antibody Service Market Size (2017-2028)
6.2 North America Monoclonal Antibody Service Market Size by Country (2017-2022)
6.3 North America Monoclonal Antibody Service Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Monoclonal Antibody Service Market Size (2017-2028)
7.2 Europe Monoclonal Antibody Service Market Size by Country (2017-2022)
7.3 Europe Monoclonal Antibody Service Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Service Market Size (2017-2028)
8.2 Asia-Pacific Monoclonal Antibody Service Market Size by Country (2017-2022)
8.3 Asia-Pacific Monoclonal Antibody Service Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Service Market Size (2017-2028)
9.2 Latin America Monoclonal Antibody Service Market Size by Country (2017-2022)
9.3 Latin America Monoclonal Antibody Service Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Service Market Size (2017-2028)
10.2 Middle East & Africa Monoclonal Antibody Service Market Size by Country (2017-2022)
10.3 Middle East & Africa Monoclonal Antibody Service Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Monoclonal Antibody Service Introduction
11.1.4 Pfizer Revenue in Monoclonal Antibody Service Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Monoclonal Antibody Service Introduction
11.2.4 Roche Revenue in Monoclonal Antibody Service Business (2017-2022)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Monoclonal Antibody Service Introduction
11.3.4 Eli Lilly Revenue in Monoclonal Antibody Service Business (2017-2022)
11.3.5 Eli Lilly Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Monoclonal Antibody Service Introduction
11.4.4 Bayer Revenue in Monoclonal Antibody Service Business (2017-2022)
11.4.5 Bayer Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Monoclonal Antibody Service Introduction
11.5.4 Amgen Revenue in Monoclonal Antibody Service Business (2017-2022)
11.5.5 Amgen Recent Development
11.6 Sanofi-Aventis
11.6.1 Sanofi-Aventis Company Detail
11.6.2 Sanofi-Aventis Business Overview
11.6.3 Sanofi-Aventis Monoclonal Antibody Service Introduction
11.6.4 Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2017-2022)
11.6.5 Sanofi-Aventis Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Monoclonal Antibody Service Introduction
11.7.4 Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2017-2022)
11.7.5 Johnson & Johnson Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Detail
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Monoclonal Antibody Service Introduction
11.8.4 Novo Nordisk Revenue in Monoclonal Antibody Service Business (2017-2022)
11.8.5 Novo Nordisk Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Monoclonal Antibody Service Introduction
11.9.4 Merck Revenue in Monoclonal Antibody Service Business (2017-2022)
11.9.5 Merck Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Detail
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Monoclonal Antibody Service Introduction
11.10.4 Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2017-2022)
11.10.5 Abbott Laboratories Recent Development
11.11 GSK
11.11.1 GSK Company Detail
11.11.2 GSK Business Overview
11.11.3 GSK Monoclonal Antibody Service Introduction
11.11.4 GSK Revenue in Monoclonal Antibody Service Business (2017-2022)
11.11.5 GSK Recent Development
11.12 BMS
11.12.1 BMS Company Detail
11.12.2 BMS Business Overview
11.12.3 BMS Monoclonal Antibody Service Introduction
11.12.4 BMS Revenue in Monoclonal Antibody Service Business (2017-2022)
11.12.5 BMS Recent Development
11.13 Alexion
11.13.1 Alexion Company Detail
11.13.2 Alexion Business Overview
11.13.3 Alexion Monoclonal Antibody Service Introduction
11.13.4 Alexion Revenue in Monoclonal Antibody Service Business (2017-2022)
11.13.5 Alexion Recent Development
11.14 UCB
11.14.1 UCB Company Detail
11.14.2 UCB Business Overview
11.14.3 UCB Monoclonal Antibody Service Introduction
11.14.4 UCB Revenue in Monoclonal Antibody Service Business (2017-2022)
11.14.5 UCB Recent Development
11.15 Seattle Genetics
11.15.1 Seattle Genetics Company Detail
11.15.2 Seattle Genetics Business Overview
11.15.3 Seattle Genetics Monoclonal Antibody Service Introduction
11.15.4 Seattle Genetics Revenue in Monoclonal Antibody Service Business (2017-2022)
11.15.5 Seattle Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Monoclonal Antibody Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Reagents
Table 3. Key Players of Drugs
Table 4. Key Players of Other
Table 5. Global Monoclonal Antibody Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Monoclonal Antibody Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Monoclonal Antibody Service Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Monoclonal Antibody Service Market Share by Region (2017-2022)
Table 9. Global Monoclonal Antibody Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Monoclonal Antibody Service Market Share by Region (2023-2028)
Table 11. Monoclonal Antibody Service Market Trends
Table 12. Monoclonal Antibody Service Market Drivers
Table 13. Monoclonal Antibody Service Market Challenges
Table 14. Monoclonal Antibody Service Market Restraints
Table 15. Global Monoclonal Antibody Service Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Monoclonal Antibody Service Market Share by Players (2017-2022)
Table 17. Global Top Monoclonal Antibody Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Service as of 2021)
Table 18. Ranking of Global Top Monoclonal Antibody Service Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Monoclonal Antibody Service Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Monoclonal Antibody Service Product Solution and Service
Table 22. Date of Enter into Monoclonal Antibody Service Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Monoclonal Antibody Service Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Monoclonal Antibody Service Revenue Market Share by Type (2017-2022)
Table 26. Global Monoclonal Antibody Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Monoclonal Antibody Service Revenue Market Share by Type (2023-2028)
Table 28. Global Monoclonal Antibody Service Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Monoclonal Antibody Service Revenue Market Share by Application (2017-2022)
Table 30. Global Monoclonal Antibody Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Monoclonal Antibody Service Revenue Market Share by Application (2023-2028)
Table 32. North America Monoclonal Antibody Service Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Monoclonal Antibody Service Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Monoclonal Antibody Service Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Monoclonal Antibody Service Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Monoclonal Antibody Service Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Monoclonal Antibody Service Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Monoclonal Antibody Service Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Monoclonal Antibody Service Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Monoclonal Antibody Service Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Monoclonal Antibody Service Market Size by Country (2023-2028) & (US$ Million)
Table 42. Pfizer Company Detail
Table 43. Pfizer Business Overview
Table 44. Pfizer Monoclonal Antibody Service Product
Table 45. Pfizer Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 46. Pfizer Recent Development
Table 47. Roche Company Detail
Table 48. Roche Business Overview
Table 49. Roche Monoclonal Antibody Service Product
Table 50. Roche Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Monoclonal Antibody Service Product
Table 55. Eli Lilly Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. Bayer Company Detail
Table 58. Bayer Business Overview
Table 59. Bayer Monoclonal Antibody Service Product
Table 60. Bayer Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 61. Bayer Recent Development
Table 62. Amgen Company Detail
Table 63. Amgen Business Overview
Table 64. Amgen Monoclonal Antibody Service Product
Table 65. Amgen Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 66. Amgen Recent Development
Table 67. Sanofi-Aventis Company Detail
Table 68. Sanofi-Aventis Business Overview
Table 69. Sanofi-Aventis Monoclonal Antibody Service Product
Table 70. Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 71. Sanofi-Aventis Recent Development
Table 72. Johnson & Johnson Company Detail
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Monoclonal Antibody Service Product
Table 75. Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Novo Nordisk Company Detail
Table 78. Novo Nordisk Business Overview
Table 79. Novo Nordisk Monoclonal Antibody Service Product
Table 80. Novo Nordisk Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 81. Novo Nordisk Recent Development
Table 82. Merck Company Detail
Table 83. Merck Business Overview
Table 84. Merck Monoclonal Antibody Service Product
Table 85. Merck Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Abbott Laboratories Company Detail
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Monoclonal Antibody Service Product
Table 90. Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 91. Abbott Laboratories Recent Development
Table 92. GSK Company Detail
Table 93. GSK Business Overview
Table 94. GSK Monoclonal Antibody ServiceProduct
Table 95. GSK Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 96. GSK Recent Development
Table 97. BMS Company Detail
Table 98. BMS Business Overview
Table 99. BMS Monoclonal Antibody ServiceProduct
Table 100. BMS Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 101. BMS Recent Development
Table 102. Alexion Company Detail
Table 103. Alexion Business Overview
Table 104. Alexion Monoclonal Antibody ServiceProduct
Table 105. Alexion Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 106. Alexion Recent Development
Table 107. UCB Company Detail
Table 108. UCB Business Overview
Table 109. UCB Monoclonal Antibody ServiceProduct
Table 110. UCB Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 111. UCB Recent Development
Table 112. Seattle Genetics Company Detail
Table 113. Seattle Genetics Business Overview
Table 114. Seattle Genetics Monoclonal Antibody ServiceProduct
Table 115. Seattle Genetics Revenue in Monoclonal Antibody Service Business (2017-2022) & (US$ Million)
Table 116. Seattle Genetics Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Service Market Share by Type: 2021 VS 2028
Figure 2. Reagents Features
Figure 3. Drugs Features
Figure 4. Other Features
Figure 5. Global Monoclonal Antibody Service Market Share by Application in 2021 & 2028
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Research & Academic Laboratories Case Studies
Figure 8. Pharmaceutical & Biotechnology Companies Case Studies
Figure 9. Monoclonal Antibody Service Report Years Considered
Figure 10. Global Monoclonal Antibody Service Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Monoclonal Antibody Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Monoclonal Antibody Service Market Share by Region: 2021 VS 2028
Figure 13. Global Monoclonal Antibody Service Market Share by Players in 2021
Figure 14. Global Top Monoclonal Antibody Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Service as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Monoclonal Antibody Service Revenue in 2021
Figure 16. North America Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Monoclonal Antibody Service Market Share by Country (2017-2028)
Figure 18. United States Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Monoclonal Antibody Service Market Share by Country (2017-2028)
Figure 22. Germany Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Monoclonal Antibody Service Market Share by Region (2017-2028)
Figure 30. China Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Monoclonal Antibody Service Market Share by Country (2017-2028)
Figure 38. Mexico Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Monoclonal Antibody Service Market Share by Country (2017-2028)
Figure 42. Turkey Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Monoclonal Antibody Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 45. Roche Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 46. Eli Lilly Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 47. Bayer Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 48. Amgen Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 49. Sanofi-Aventis Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 50. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 51. Novo Nordisk Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 52. Merck Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 53. Abbott Laboratories Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 54. GSK Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 55. BMS Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 56. Alexion Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 57. UCB Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 58. Seattle Genetics Revenue Growth Rate in Monoclonal Antibody Service Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Roche Eli Lilly Bayer Amgen Sanofi-Aventis Johnson & Johnson Novo Nordisk Merck Abbott Laboratories GSK BMS Alexion UCB Seattle Genetics